Junge, W., Heger-Mahn, D., Trummer, D., & Merz, M. (2013). Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared with a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study. Springer International Publishing.
Chicago Style CitationJunge, Wolfgang, Doris Heger-Mahn, Dietmar Trummer, i Martin Merz. Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared With a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study. Springer International Publishing, 2013.
Cita MLAJunge, Wolfgang, Doris Heger-Mahn, Dietmar Trummer, i Martin Merz. Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared With a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study. Springer International Publishing, 2013.